Thomas Koch, Sebastian von Peter, Stefan Weinmann, Guillermo Ruiz-Pérez
{"title":"[Reduction and discontinuation of antipsychotics and antidepressants: Comparative assessment by outpatient psychiatrists].","authors":"Thomas Koch, Sebastian von Peter, Stefan Weinmann, Guillermo Ruiz-Pérez","doi":"10.1007/s40211-026-00583-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate physicians' perspectives on the tapering and discontinuation (R&D) of antidepressants (AD) and antipsychotics (AP).</p><p><strong>Methods: </strong>In ten systematic interviews and a focus group with outpatient psychiatrists from Berlin and Brandenburg, differences in assessments, counseling practices, and decision-making patterns were recorded and subsequently with MAXQDA inductively evaluated.</p><p><strong>Results: </strong>R&D is initiated more frequently in AD because depressed patients are considered more insightful and adherent to treatment. In contrast, psychiatrists perceive the risk of relapse and the consequences of discontinuing AP to be higher, leading to more reluctance to initiate R&A. Structural barriers, unclear guidelines, and a lack of non-pharmacological alternatives make R&A difficult, particularly in cases of psychosis.</p><p><strong>Conclusion: </strong>More participatory R&D practices require clear guidelines, knowledge transfer, and improved psychosocial care services-especially for patients with psychosis.</p>","PeriodicalId":44560,"journal":{"name":"NEUROPSYCHIATRIE","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2026-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEUROPSYCHIATRIE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40211-026-00583-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The aim of this study was to investigate physicians' perspectives on the tapering and discontinuation (R&D) of antidepressants (AD) and antipsychotics (AP).
Methods: In ten systematic interviews and a focus group with outpatient psychiatrists from Berlin and Brandenburg, differences in assessments, counseling practices, and decision-making patterns were recorded and subsequently with MAXQDA inductively evaluated.
Results: R&D is initiated more frequently in AD because depressed patients are considered more insightful and adherent to treatment. In contrast, psychiatrists perceive the risk of relapse and the consequences of discontinuing AP to be higher, leading to more reluctance to initiate R&A. Structural barriers, unclear guidelines, and a lack of non-pharmacological alternatives make R&A difficult, particularly in cases of psychosis.
Conclusion: More participatory R&D practices require clear guidelines, knowledge transfer, and improved psychosocial care services-especially for patients with psychosis.
期刊介绍：
Die Zeitschrift ist das offizielle Organ der „Österreichischen Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik (ÖGPP)'', und wissenschaftliches Organ der Österreichischen Alzheimer Gesellschaft, der Österreichischen Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, der Österreichischen Schizophreniegesellschaft, und der pro mente austria - Österreichischer Dachverband der Vereine und Gesellschaften für psychische und soziale Gesundheit.Sie veröffentlicht Übersichten zu relevanten Themen des Fachs, Originalarbeiten, Kasuistiken sowie Briefe an die Herausgeber. Zudem wird auch Buchbesprechungen sowie Neuigkeiten aus den Bereichen Personalia, Standes- und Berufspolitik sowie Kongressankündigungen Raum gewidmet.Thematisch ist das Fach Psychiatrie und die Methoden der Psychotherapie in allen ihren Facetten vertreten. Die Zeitschrift richtet sich somit an alle Berufsgruppen, die sich mit Ursachen, Erscheinungsformen und Behandlungsmöglichkeiten von psychischen Störungen beschäftigen. -----------------------------------------------------------------------------------------------------· The professional and educational journal of the Austrian Society of Psychiatry, Psychotherapy and Psychosomatics (Österreichische Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik; ÖGPP) and the Austrian Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (Österreichische Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie; ÖGKJP)· Overviews of all relevant topics pertaining to the discipline· Intended for all occupational groups committed to the causes and manifestations of, as well as therapy options for psychic disorders· All manuscripts principally pass through a double-blind peer review process involving at least two independent expertsThe official journal of the Austrian Societies of Psychiatry, Psychotherapy and Psychosomatics (ÖGPP) and Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (ÖGKJP)The journal publishes overviews of relevant issues in the field, original work, case reports and letters to the editors. In addition, space is devoted to book reviews, news from the areas of personnel matters and professional policies, and conference announcements.Thematically, the discipline of psychiatry and the methods of psychotherapy are represented in all their facets. The journal is thus aimed at all professional groups committed to the causes and manifestations of, as well as therapy options for psychic disorders
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
